Business Wire

Lumicell Announces FDA Acceptance and Priority Review of New Drug Application for LUMISIGHT™ Optical Imaging Agent for Breast Cancer

NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced the U.S. Food and Drug ...
Business Wire

Lumicell Co-Founder Moungi Bawendi Awarded Nobel Prize in Chemistry

NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced company co-founder Moungi G.
KHON2

Lumicell Granted Permanent HCPCS Code for Intraoperative Fluorescence Imaging Margin Assessment

Permanent HCPCS code granted following U.S. FDA approval of LUMISIGHT™ (pegulicianine) and Lumicell™ Direct Visualization System (DVS), together referred to as LumiSystem™, with commercial ...
FierceBiotech

FDA approves Lumicell’s fluorescent system for highlighting residual breast cancer tissue

The FDA has granted a groundbreaking approval to a fluorescent light system that illuminates leftover breast cancer tissue in real-time during surgery—to help ensure a thorough removal of the tumor ...
BioWorld

Lumicell shines a light on residual breast cancer with FDA approvals

Lumicell Inc. sees a brighter future now that it has secured U.S. FDA approval for both its new drug application for Lumisight (pegulicianine) optical imaging agent and premarket approval for the ...
MedPage Today

FDA Greenlights Imaging Agent to Detect Residual Cancer After Lumpectomy

The FDA approved pegulicianine (LumiSight) as an optical imaging agent for detecting residual cancer after breast-conserving surgery (BCS). The approval stipulates use of pegulicianine with the ...
Joplin Globe

Lumicell’s LumiSystem™ Featured on Viewpoint with Dennis Quaid for New Episode on Fluorescence-Imaging Guidance During Lumpectomy Surgery

Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, is thrilled to announce its upcoming ...
Medscape

Novel Fluorescence Guidance Improves Lumpectomy Outcomes

As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...